Replies to post #90553 on Cytodyn Inc (CYDY)

[saxxie2]

As I recall Trump had previously mentioned an HIV therapy that was being looked at for COVID! Hello!

[Chasing Wealth]

Do you see the others drugs the FDA knocked out this past week? Our drug was not one of them. Leron is still in the running, and with the massive run up last week with no news. It can only mean that your DRs, FDA, Nurses, people being treated already know how great this drug and it was a retail run-up. Retail buyers put stop losses in as they head to their other jobs which the HIT PIECE was the only way to get enough money in to short the momentum. Wild Ride still coming!

[HFM2]

You might consider Brilacidin from Innovation Pharmaceuticals - certainly producing strong results as tested to this point.

[powerwalker]

VC, if Leronlimab were showing strong results, the Data and Safety Monitoring Board (DSMB) might step in and recommend swifter approval due to clear safety and efficacy results. Given the increases in CV-19 cases across the country, DSMB might be very interested in the drug's results so far.

https://www.nidcr.nih.gov/research/human-subjects-research/interventional-studies/data-and-safety-monitoring-board-guidelines

P.S. I would not think any announcement on HCQ, as noted earlier, would cause any market changing impact to its provider(s).